Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 06/30/22
Due: 06/30/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients | NCT02058680 | OncBioMune Pharmaceuticals | user2@example.com | None | 2012-04-30 | 2018-12-31 | 2019-12-31 | - | - | 2025-07-14 |
| Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance | NCT03579654 | OncBioMune Pharmaceuticals | user2@example.com | None | 2019-02-28 | 2022-06-30 | 2023-06-30 | - | - | 2025-07-14 |